RA
LLY icon

Ruggaard & Associates’s Eli Lilly LLY Stock Holding History

Ruggaard & Associates’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$524K Hold
437
– – 0.19% 72
2026
Q1 		$402K Hold
437
– – 0.16% 80
2025
Q4 		$470K Sell
437
-9
-2% -$8.61K 0.18% 71
2025
Q3 		$340K Hold
446
– – 0.13% 87
2025
Q2 		$348K Hold
446
– – 0.14% 85
2025
Q1 		$368K Buy
446
+3
+0.7% +$2.5K 0.16% 81
2024
Q4 		$342K Sell
443
-133
-23% -$110K 0.15% 82
2024
Q3 		$510K Hold
576
– – 0.22% 64
2024
Q2 		$521K Buy
576
+9
+2% +$7.2K 0.24% 62
2024
Q1 		$441K Buy
567
+12
+2% +$8.54K 0.21% 67
2023
Q4 		$324K Sell
555
-15
-3% -$8.76K 0.17% 83
2023
Q3 		$306K Sell
570
-14
-2% -$7.21K 0.18% 78
2023
Q2 		$274K Sell
584
-39
-6% -$16.4K 0.16% 89
2023
Q1 		$214K Buy
+623
New +$210K 0.13% 97

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ruggaard & Associates's LLY Position: Q2 2026 in Review

Ruggaard & Associates held its Eli Lilly (LLY) position steady in Q2 2026 at 437 shares worth $524K. The position accounts for 0.19% of the portfolio, ranked #72.

Ruggaard & Associates first reported a position in LLY in Q1 2023 and has held it in 14 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Ruggaard & Associates held 437 shares of Eli Lilly worth $524K as of Q2 2026.
  • Ruggaard & Associates left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.19% of Ruggaard & Associates's portfolio in Q2 2026, its #72 holding.
  • Ruggaard & Associates first reported a position in Eli Lilly in Q1 2023 and has held it in 14 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ruggaard & Associates's 13F filing for Q2 2026, filed 17 Aug 2026.